SBIR/STTR Award attributes
Production of renewable products using engineered microorganisms have largely not achieved the yields, titers and productivities required for large scale market adoption. Invizyne Technologies has developed cell-free enzymatic systems that have the potential to increase the overall efficiency of the conversion process and bring down the cost of renewable products. A Techno Economic Analysis identified the cost of using purified cofactors as a main driver of cost of cell-free bioconversions. Bringing down the cost of cofactors will be a critical improvement that will allow for the widespread adoption of this technology. We will bring down the cost of cofactors by developing an alternative process to incorporate low-cost crude cofactor mixes from microbial waste streams. In phase I we quantified the cofactor pools in industrial strains of yeast and E. coli and demonstrated that they can be effectively integrated into a cell-free enzymatic reaction to make terpenes. In phase II we enriched these lysates in for high concentrations of ATP and used them to produce long chain carotenoid Beta carotene. In phase IIA we plan to continue development on generating ATP from microbial waste and implementing cell free enzymatic pathways to run inside this enriched cofactor lysate. The crude cofactors sourced from industrial E. coli or yeast to produce an initial carotenoid product called astaxanthin. Our end goal is to produce astaxanthin at industrial relevant titers and scales (10g/L at a 10L scale). Cell free enzymatic bioconversions have the potential to revolutionize the green chemicals industry by lowering the overall cost of production. This cell free approach can also make bio-based chemicals that are impossible to produce in organisms because of their toxicity and therefore can be used to make rare and expensive chemicals more accessible.
